Pfizer Inc logo

Pfizer Inc

$ 43.09 -1.03 (-2.33%) 10:09 PM EST
P/E:
8.40
P/B:
2.75
Market Cap:
$ 241.84B
Enterprise V:
$ 254.60B
Volume:
21.78M
Avg Vol (2M):
18.27M
Also Trade In:
Volume:
21.78M
Market Cap $:
241.84B
PE Ratio:
8.40
Avg Vol (2-Month):
18.27M
Enterprise Value $:
254.60B
PB Ratio:
2.75
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for PFE (Pfizer Inc) from 1990 to Oct 06 2022. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Pfizer stock (PFE) PE ratio as of Oct 06 2022 is 8.4. More Details

Pfizer PE Ratio (TTM) Chart

To

Pfizer PE Ratio (TTM) Historical Data

Total 1202
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Pfizer PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2022-10-078.4 2022-08-039.8
2022-10-058.6 2022-08-029.7
2022-10-048.7 2022-08-019.9
2022-10-038.6 2022-07-299.9
2022-09-308.6 2022-07-289.9
2022-09-298.6 2022-07-2710.2
2022-09-288.7 2022-07-2610.2
2022-09-278.6 2022-07-2510.1
2022-09-268.6 2022-07-2210.0
2022-09-238.6 2022-07-2110.0
2022-09-228.7 2022-07-209.9
2022-09-218.6 2022-07-1910.1
2022-09-208.8 2022-07-189.9
2022-09-198.9 2022-07-1510.1
2022-09-169.0 2022-07-1410.1
2022-09-159.0 2022-07-1310.1
2022-09-149.0 2022-07-1210.2
2022-09-139.0 2022-07-1110.3
2022-09-129.3 2022-07-0810.4
2022-09-099.4 2022-07-0710.4
2022-09-089.2 2022-07-0610.3
2022-09-079.0 2022-07-0510.1
2022-09-068.9 2022-07-0110.2
2022-09-028.9 2022-06-3010.3
2022-09-019.1 2022-06-2910.0
2022-08-318.8 2022-06-289.9
2022-08-309.0 2022-06-2711.9
2022-08-299.1 2022-06-2411.8
2022-08-269.2 2022-06-2311.5
2022-08-259.4 2022-06-2211.3
2022-08-249.3 2022-06-2111.0
2022-08-239.4 2022-06-1710.7
2022-08-229.6 2022-06-1610.9
2022-08-199.6 2022-06-1511.1
2022-08-189.5 2022-06-1411.0
2022-08-179.6 2022-06-1311.0
2022-08-169.8 2022-06-1011.5
2022-08-159.7 2022-06-0911.9
2022-08-129.8 2022-06-0812.3
2022-08-119.4 2022-06-0712.4
2022-08-109.8 2022-06-0612.2
2022-08-099.7 2022-06-0312.2
2022-08-089.7 2022-06-0212.1
2022-08-059.6 2022-06-0112.0
2022-08-049.8 2022-05-3112.2

Pfizer PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.